chr16-11254001-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000572173.1(RMI2):​c.-516+4223T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.393 in 150,650 control chromosomes in the GnomAD database, including 12,708 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as no classification for the single variant (no stars).

Frequency

Genomes: 𝑓 0.39 ( 12708 hom., cov: 28)

Consequence

RMI2
ENST00000572173.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.444

Publications

48 publications found
Variant links:
Genes affected
RMI2 (HGNC:28349): (RecQ mediated genome instability 2) RMI2 is a component of the BLM (RECQL3; MIM 604610) complex, which plays a role in homologous recombination-dependent DNA repair and is essential for genome stability (Xu et al., 2008 [PubMed 18923082]).[supplied by OMIM, Nov 2008]
SOCS1 (HGNC:19383): (suppressor of cytokine signaling 1) This gene encodes a member of the STAT-induced STAT inhibitor (SSI), also known as suppressor of cytokine signaling (SOCS), family. SSI family members are cytokine-inducible negative regulators of cytokine signaling. The expression of this gene can be induced by a subset of cytokines, including IL2, IL3 erythropoietin (EPO), CSF2/GM-CSF, and interferon (IFN)-gamma. The protein encoded by this gene functions downstream of cytokine receptors, and takes part in a negative feedback loop to attenuate cytokine signaling. Knockout studies in mice suggested the role of this gene as a modulator of IFN-gamma action, which is required for normal postnatal growth and survival. [provided by RefSeq, Jul 2008]
SOCS1 Gene-Disease associations (from GenCC):
  • autoinflammatory syndrome with immunodeficiency
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), ClinGen
  • autoimmune disease
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000572173.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.714 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000572173.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RMI2
ENST00000572173.1
TSL:1
c.-516+4223T>C
intron
N/AENSP00000461206.1Q96E14-2
SOCS1
ENST00000644787.2
c.*842A>G
3_prime_UTR
Exon 1 of 1ENSP00000496577.1
RMI2
ENST00000573910.1
TSL:3
n.160+4223T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.392
AC:
59062
AN:
150532
Hom.:
12668
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.448
Gnomad AMI
AF:
0.300
Gnomad AMR
AF:
0.532
Gnomad ASJ
AF:
0.385
Gnomad EAS
AF:
0.734
Gnomad SAS
AF:
0.588
Gnomad FIN
AF:
0.317
Gnomad MID
AF:
0.385
Gnomad NFE
AF:
0.301
Gnomad OTH
AF:
0.391
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.393
AC:
59161
AN:
150650
Hom.:
12708
Cov.:
28
AF XY:
0.403
AC XY:
29622
AN XY:
73504
show subpopulations
African (AFR)
AF:
0.449
AC:
18347
AN:
40894
American (AMR)
AF:
0.533
AC:
8051
AN:
15108
Ashkenazi Jewish (ASJ)
AF:
0.385
AC:
1334
AN:
3468
East Asian (EAS)
AF:
0.734
AC:
3723
AN:
5074
South Asian (SAS)
AF:
0.590
AC:
2805
AN:
4758
European-Finnish (FIN)
AF:
0.317
AC:
3264
AN:
10304
Middle Eastern (MID)
AF:
0.394
AC:
115
AN:
292
European-Non Finnish (NFE)
AF:
0.301
AC:
20426
AN:
67752
Other (OTH)
AF:
0.394
AC:
824
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1686
3372
5058
6744
8430
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
564
1128
1692
2256
2820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.343
Hom.:
34861
Bravo
AF:
0.416
Asia WGS
AF:
0.624
AC:
2167
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
8.9
DANN
Benign
0.70
PhyloP100
0.44
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs4780355;
hg19: chr16-11347858;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.